Fact CheckerSign in

NCT06685133Active, not recruiting

Prospective Evaluation of the Tool-in-lesion Technology of the Galaxy System in Routine Clinical Practice

A Prospective Observational Study Evaluating the Accuracy of the Tool-in-lesion Technology of the Galaxy SystemTM in Normal Clinical Practice

Source: ClinicalTrials.gov · Last updated 15 Aug 2025

Brief summary (registry, in English)

A prospective observational study evaluating the accuracy of the tool-in-lesion technology of the Galaxy SystemTM in normal clinical practice.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
50 (estimated)
First submitted
9 Nov 2024
Start date
8 Nov 2024
Primary completion date
30 Oct 2025
Lead sponsor
Noah Medical
Diseases
Lung cancer
NCT number
NCT06685133

What you commit to

  • Study type: Observational
  • Planned participants: 50
  • From 8 Nov 2024 to the primary completion date, 30 Oct 2025
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Uncontrolled coagulopathy or bleeding disorders
  • Ongoing systemic infection
  • History of lobectomy or pneumonectomy

Other

  • Known pregnancy or breastfeeding
  • Patients with pure ground-glass nodules on pre-procedural chest CT
  • Patients with pacemakers or defibrillators
  • Unsuitable for bronchoscopy procedure under general anesthesia as agreed by the treating clinician and anesthetist
  • Patients with pleural effusion or diaphragmatic paralysis

Who the study is looking for

  • Age ≥ 18
  • Patients with indeterminate lung nodule
  • Peripheral pulmonary subsolid and solid nodules (PPNs) sized up to 3 cm measured as the largest dimension based on the pre-procedural CT
  • Pre-procedural CT is conducted within 90 days of the bronchoscopy procedure
  • Informed consent properly obtained per local regulations

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHI Memorial Hospital
Coordinator of this site? Confirm its status
ChattanoogaUnited StatesUnknown status
Inova Fairfax Medical Campus
Coordinator of this site? Confirm its status
Falls ChurchUnited StatesUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.